Clinical Trials Sponsored by Fondazione del Piemonte per l'Oncologia

Total 80 results

Fondazione del Piemonte per l'Oncologia

Completed

A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP) (AGNOSTOS)

Unknown Primary Tumors

Italy
Fondazione del Piemonte per l'Oncologia

Completed

Detection Rate of Prostate Cancer in Men Undergoing MRI

Prostatic Neoplasm

Italy
Fondazione del Piemonte per l'Oncologia

Unknown

Prospective Observational Study of Antitumor Activity Correlation Between Hormonal Therapy and Expression miRNA100 (BC-P1-2013)

Breast Cancer

Italy
Fondazione del Piemonte per l'Oncologia

Unknown

Cardiotoxicity and Risk Factors in Patients With Colorectal Cancer Receiving Fluoropyrimidine

Colorectal Cancer

Italy
Fondazione del Piemonte per l'Oncologia

Unknown

Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors

Cholangiocarcinoma

Italy
Fondazione del Piemonte per l'Oncologia

Recruiting

SUNNYDAY: SUbepithelialgastroiNtestiNal Tumors Detection,accuracYDiAgnosis,ElastographY and Contrast-enhanced EUS (SunnyDay021)

Subepithelial Gastrointestinal Tumors

Italy
Fondazione del Piemonte per l'Oncologia

Recruiting

Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer (RETURN)

Prostate Cancer

Italy
Fondazione del Piemonte per l'Oncologia

Recruiting

Early Detection of Relapses in Stage IV Colorectal Cancer Patients (REDCLOUD)

Metastatic Colorectal Cancer

Italy
Fondazione del Piemonte per l'Oncologia

Completed

Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance (CHRONOS)

Colorectal Cancer

Italy
Fondazione del Piemonte per l'Oncologia

Completed

Comparison of Multi-parametric and Bi-parametric Magnetic Resonance Imaging in Men With Suspicion of Prostate Cancer

Prostatic Neoplasm

Italy
Fondazione del Piemonte per l'Oncologia

Unknown

Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib. (RESCUE)

Metastatic Colorectal Cancer

Italy
Fondazione del Piemonte per l'Oncologia

Unknown

Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical Trials (FUNNEL)

Metastatic Colorectal Cancer

Italy
Fondazione del Piemonte per l'Oncologia

Unknown

Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease (PROFILING)

Solid Tumors

Italy
Fondazione del Piemonte per l'Oncologia

Completed

Role of the MET Oncogene in Human Colorectal Cancer - A Translational Study (COMET)

Colorectal Cancer

Italy
Fondazione del Piemonte per l'Oncologia

Unknown

Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)

Gastrointestinal Stromal Tumor (GIST)

Italy
Fondazione del Piemonte per l'Oncologia

Unknown

MR-targeted vs. Random TRUS-guided Prostate Biopsy (Pro-Cure2014)

Prostate Cancer

Italy
Fondazione del Piemonte per l'Oncologia

Recruiting

INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations (INSIDE)

Prostate Cancer

Italy
Fondazione del Piemonte per l'Oncologia

Completed

Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal Tumors (PI-CaP)

Peritoneal Carcinomatosis

Italy
Fondazione del Piemonte per l'Oncologia

Unknown

Evaluation of Trastuzumab in Combination With Lapatinib or Pertuzumab in Combination With Trastuzumab-Emtansine to Treat Patients With HER2-positive Metastatic Colorectal Cancer (HERACLES)

Metastatic Colorectal Cancer

Italy
Fondazione del Piemonte per l'Oncologia

Unknown

Radiotherapy After Mastectomy for Breast Cancer Patients at Increased Risk of Local Recurrence

Breast Cancer
Fondazione del Piemonte per l'Oncologia

Unknown

Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant

Hematological Malignancies

Italy
Prof. Massimo Aglietta

Completed

Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenocarcinoma (Vecti-BIL)

Biliary Carcinoma

Italy
Fondazione del Piemonte per l'Oncologia
San Luigi Gonzaga Hospital

Recruiting

Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention (RIDERS)

Cancer of Prostate

Italy
Fondazione del Piemonte per l'Oncologia
Alleanza Contro il Cancro

Recruiting

The ACC Preclinical Research Platform for Precision Oncology (ACC Platform)

Hematologic Neoplasms | Solid Tumor

Italy
Niguarda Hospital
University of Turin, Italy; Fondazione del Piemonte per l'Oncologia

Completed

Donation of Post Mortem Tumor Tissues (DONUM)

NSCLC Stage IV | CRC | CUP

Italy
Fondazione del Piemonte per l'Oncologia
Università degli Studi di Trento; Ospedale Santa Croce-Carle Cuneo

Recruiting

The Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint Inhibitors (PRINCESS)

Head and Neck Squamous Cell Carcinoma

Italy
Fondazione del Piemonte per l'Oncologia
San Luigi Gonzaga Hospital; Epidemiology and Screening Unit - CPO, Turin, Italy

Not yet recruiting

Prostate Cancer Screening: a Pilot Study (ProScreenMRI)

Prostate Cancer

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)

MANTLE CELL LYMPHOMA

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL) (HD0803)

Hodgkin Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma (FLE09)

Follicular Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients (HD0801)

Hodgkin's Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Unknown

Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma (REAL07)

Follicular Lymphoma | Non Hodgkin Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Unknown

Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma (DLCL04)

Diffuse Large B-Cell Lymphoma | IPI≥2

Italy
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia (DECI2009)

Chronic Myelomonocytic Leukemia

Italy
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Terminated

Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts

Myelodysplastic Syndromes

Italy
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Terminated

Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes

Myelodysplastic Syndromes

Italy
Fondazione Italiana Linfomi ONLUS
Janssen Pharmaceutica; Janssen-Cilag Ltd.; Centro di Riferimento per l'Epidemiologia...

Completed

Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP. (FIL_VERAL12)

Diffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-cell Lymphoma Refractory

Italy
Università degli Studi del Piemonte Orientale "Amedeo...
Lega Italiana per la Lotta contro i Tumori

Completed

The Impact of Brief Motivational Counseling for Smoking Cessation in an Italian Emergency Department: a Randomized Controlled Trial

Smoking Habit

Italy
Gruppo Italiano Multiregionale per lo studio dei...
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients (CFM)

Lymphoblastic Lymphoma | Diffuse Large Cell Lymphoma | Burkitt's Lymphoma

Italy
Gruppo Italiano Multiregionale per lo studio dei...
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Terminated

Zevalin Twice in Aggressive Non-Hodgkin Lymphoma

Diffuse Large B-Cell Lymphoma

Italy
Gruppo Italiano Multiregionale per lo studio dei...
University of Turin, Italy; Fondazione Italiana Linfomi ONLUS; Centro di Riferimento...

Completed

Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma (LYM-2023)

Lymphoma | Non-Hodgkin Lymphoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Associazione Italiana per la Ricerca sul Cancro

Unknown

Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets

Desmoid Type-fibromatosis

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Associazione Italiana per la Ricerca sul Cancro

Completed

HIPEC Using High Intra-abdominal Pressure (HIPEC-IAP)

Colorectal Cancer | Pseudomyxoma Peritonei

Italy
Institut Català d'Oncologia
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; University of Aberdeen and other collaborators

Unknown

Environmental Assessment of Secondhand Smoke Exposure in Private Settings and Outdoor Settings in Europe

Second Hand Tobacco Smoke

Spain
Centro di Riferimento per l'Epidemiologia e la...
Associazione Italiana per la Ricerca sul Cancro; Azienda Sanitaria Locale di... and other collaborators

Completed

The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening.

Breast Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...
Istituto Europeo di Oncologia IEO MILANO

Active, not recruiting

Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors (LuX)

Neuroendocrine Tumors | Gastro Entero Pancreatic Neuroendocrine Tumors

Italy
Institut Català d'Oncologia
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; University of Aberdeen and other collaborators

Completed

Air Quality Feedback to Reduce Second-hand Smoke (SHS) Exposure in the Home (TackSHSWP4)

Tobacco Use | Tobacco Smoking | Second Hand Tobacco Smoke
Carlo Chiesa
Associazione Italiana per la Ricerca sul Cancro

Recruiting

Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry (131THEROPT124)

Metastatic Differentiated Thyroid Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Ministry of Health, Italy; Associazione Italiana per la Ricerca sul Cancro

Completed

Early Lung Cancer Detection in High Risk Individuals (MILD)

Lung Cancer

Italy
Centre Hospitalier Intercommunal de Toulon La Seyne...
Fondation Apicil

Completed

Regional Anesthesia by PENG-Block in Emergency Department (ED-PENGBLOCK)

Hip Fractures

France

Clinical Trials Sponsored by Fondazione del Piemonte per l'Oncologia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations